Publications by authors named "Susan Gueble"

Claim this Profile
D
DNA repair helicases: from mechanistic understanding to therapeutic implications.
Vijay Menon, Susan E Gueble

NAR Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Strategies for Improved Treatment of O6-Methylguanine-DNA Methyltransferase Promoter-Methylated Glioma.
Juan C Vasquez, Ranjit S Bindra, Susan E Gueble

Med Res Arch· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes following brachytherapy for endometrial cancer patients with narrow vaginal anatomy.
Bethel Adefres, Christopher J Tien, Susan Gueble, Shari Damast

Brachytherapy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage response profile distinguishes poor-acting gliomas with shared methylome signatures.
Nalin Leelatian, Charu Singh, Richard Bouffard, Ranjini K Sundaram, Kirsten E Diggins, Susan E Gueble

Neuro Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.
Matthew McCord, Thomas Sears, Wenxia Wang, Rahul Chaliparambil, Shejuan An, Susan Gueble

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Syngeneic Murine Glioma Models with Somatic Mismatch Repair Deficiency to Study Therapeutic Responses to Alkylating Agents and Immunotherapy.
Deepti Bhatt, Ranjini K Sundaram, Karla S Lugo López, Teresa Lee, Susan E Gueble

Curr Protoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.
Eric D Huseman, Anna Lo, Olga Fedorova, James L Elia, Susan E Gueble

J Am Chem Soc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
Susan E Gueble, Juan C Vasquez, Ranjit S Bindra

Curr Treat Options Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-based design of agents that selectively target drug-resistant glioma.
Kingson Lin, Susan E Gueble, Ranjini K Sundaram, Eric D Huseman, Ranjit S Bindra

Science· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncometabolites as Regulators of DNA Damage Response and Repair.
Susan E Gueble, Ranjit S Bindra

Semin Radiat Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51.
Alanna R Kaplan, Susan E Gueble, Yanfeng Liu, Sebastian Oeck, Hoon Kim

Sci Transl Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis